Roles of hepatocyte growth factor and transforming growth factor β1 in production of extracellular matrix by canine vocal fold fibroblasts

Laryngoscope

Volumn 113, Issue 1, 2003, Pages 144-148

  Hirano, Shigeru ^a,b   Bless, Diane ^a   Heisey, Dennis ^a   Ford, Charles ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

Extracellular matrix; Fibroblast; Fibrosis; Hepatocyte growth factor; Transforming growth factor 1; Vocal fold

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; HYALURONIC ACID; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROBLAST CULTURE; FIBROSIS; LAMINA PROPRIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SUPERNATANT; VOCAL CORD;

ANALYSIS OF VARIANCE; ANIMALS; CELLS, CULTURED; COLLAGEN TYPE I; CULTURE MEDIA; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; FIBRONECTINS; HEPATOCYTE GROWTH FACTOR; HYALURONIC ACID; PROBABILITY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VOCAL CORDS;

EID: 0037221657     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200301000-00027     Document Type: Article

References (29)

1. Hirano M, Sato K, Nakashima T. Fibroblasts in human vocal fold mucosa. Acta Otolaryngol (Stockh) 1999;119:271-276.
2. Gray SD, Titze IR, Alipour F, Hammond TH. Biomechanical and histologic observations of vocal fold fibrous proteins. Ann Otol Rhinol Laryngol 2000;109:77-85.
3. Gray SD, Titze IR, Chan R, Hammond TH. Vocal fold proteoglycans and their influence on biomechanics. Laryngoscope 1999;109:845-854.
4. Ehrlich HP. Collagen considerations in scarring and regenerative repair. In: Garg HG, Longaker MT, eds. Scarless Wound Healing. New York: Marcel Dekker, 2000:99-113.
5. Low SQ, Moy RL. Scar wars strategies. Target collagen. J Dermatol Surg Oncol 1992;18:981-986.
6. Hermanns S, Reiprich P, Muller HW. A reliable method to reduce collagen scar formation in the lesioned rat spinal cord. J Neurosci Methods 2001;110:141-146.
7. Hirano M. Phonosurgery. Basic and clinical investigation. Otologia (Fukuoka) 1975;21(suppl 1):299-303.
8. Rogerson AR, Clark KF, Bandi SR, Bane B. Voice and healing after vocal fold epithelium removal by CO2 laser vs. microlaryngeal stripping. Otolaryngol Head Neck Surg 1996;115:352-359.
9. Thibeault SL, Gray SD, Bless DM, Chan RW, Ford CN. Histologic and rheologic characterization of vocal fold scarring. J Voice 2002;16:96-104.
10. Ford CN. Advances and refinements in phonosurgery. Laryngoscope 1999;109:1891-1900.
11. Benninger MS, Alessi D, Archer S, et al. Vocal fold scarring: Current concepts and management. Otolaryngol Head Neck Surg 1996;115:474-482.
12. Balazs EA, Larsen NE. Hyaluronan: Aiming for perfect skin regeneration. In: Garg HG, Longaker MT, eds. Scarless Wound Healing. New York: Marcel Dekker, 2000:143-160.
13. Matsumoto K, Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 1997;239:639-644.
14. Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 2001;21:437-451.
15. Broadley C, Gonzalez DA, Nair R, Koriwchak MJ, Ossoff R, Davidson JM. A tissue-culture model for the study of canine vocal fold fibroblasts. Laryngoscope 1995;105:23-27.
16. Ozaki I, Zhao G, Mizuta T, et al. Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line. J Hepatol 2002;36:169-178.
17. Chan RW, Titze IR. Hyaluronic acid (with fibronectin) as a bioimplant for the vocal fold mucosa. Laryngoscope 1999;109:1142-1149.
18. Ruoslahti E. Fibronectin and its receptors. Annu Rev Biochem 1988;57:375-413.
19. Grinnell F. Fibronectin and wound healing. J Cell Biochem 1984;26:107-116.
20. Thibeault SL, Gray SD, Li W, Ford CN, Smith ME, Davis RK. Genotypic and phenotypic expression of vocal fold polyps and Reinke's edema: A preliminary study. Ann Otol Rhinol Laryngol 2002;111:302-309.
21. Gray SD, Mammond E, Hanson DF. Benign pathologic responses of the larynx. Ann Otol Rhinol Laryngol 1995;104:13-18.
22. Brzozowski T, Konturek PC, Konturek SJ, et al. Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and -2. Digestion 2001;64:15-29.
23. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
24. Fraser JRE, Laurent TC. Hyaluronan. In: Comper WD, ed. Extracellular Matrix. Vol 2. Amsterdam: Harwood Academic, 1996:141-199.
25. Thibeault SL, Li W, Gray SD, Chen Z. Instability of extracellular matrix gene expression in primary cell culture of fibroblasts from human vocal fold lamina propria and tracheal scar. Ann Otol Rhinol Laryngol 2002;111:8-14.
26. Savage K, Swann DA. Comparison of glycosaminoglycan synthesis by human fibroblasts from normal skin, normal scar, and hypertrophic scar. J Invest Dermatol 1985;84:521-526.
27. Matsuda Y, Matsumoto K, Ichida T, Nakamura T. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem 1995;118:643-649.
28. Zhou LJ, Ono I, Kaneko F. Role of transforming growth factor-beta 1 in fibroblasts derived from normal and hypertrophic scarred skin. Arch Dermatol Res 1997;289:646-652.
29. Berke G, Blumin J, Sebastian J, Keller G, Revazova E. Vocal cord augmentation with cultured autologous fibroblasts. Bull Exp Biol Med 2000;130:790-792.